Ismailov S.I.

5 та иш

1 Tashkent Pediatric Medical Institute ,

1. INSULINORESISTANCE IN PATIENTS WITH FIBROCYSTIC MASTOPATHY, AND THE EFFECT OF METFORMIN ON IT.

   Ismailov S.I., Yuldashev O.S.,, Sultanov Sh.B +1

   МақолаHermeneutics and Narrative IdentityZenodo (CERN European Organization for Nuclear Research)20220 иқтибос

   ABIABI:AkademIndex/openalex/2022.article.003312

2. Prospects for the use of artificial intelligence technologies in predicting the risk of cardiovascular disease (CVD) outcomes in patients with type 2 diabetes mellitus

   Alimova D.A., Alisher Ikramov, Trigulova R.Kh. +4

   МақолаHermeneutics and Narrative IdentityZenodo (CERN European Organization for Nuclear Research)20220 иқтибос

   ABIABI:AkademIndex/openalex/2022.article.007831

3. Prospects for the use of artificial intelligence technologies in predicting the risk of cardiovascular disease (CVD) outcomes in patients with type 2 diabetes mellitus

   Alimova D.A., Alisher Ikramov, Раиса Тригулова +4

   МақолаHermeneutics and Narrative IdentityZenodo (CERN European Organization for Nuclear Research)20220 иқтибос

   ABIABI:AkademIndex/openalex/2022.article.009276

4. Prospects for the use of artificial intelligence technologies in predicting the risk of cardiovascular disease (CVD) outcomes in patients with type 2 diabetes mellitus

   Alimova D.A., Alisher Ikramov, Раиса Тригулова +4

   МақолаHealthcare Systems and Public HealthZenodo (CERN European Organization for Nuclear Research)20230 иқтибос

   ABIABI:AkademIndex/openalex/2023.article.005541

5. SECONDARY HYPERPARATHYROIDISM: PATHOGENESIS AND CLINICAL ASPECTS

   Ju Seunghwan, Ismailov S.I., Shamansurova Z.M.

   МақолаDigestive system and related healthZenodo (CERN European Organization for Nuclear Research)20230 иқтибос

   ABIABI:AkademIndex/openalex/2023.article.010220